|
APC Natural Research |
|
|
Research Analysis |
|
Phase III Objective:
The objective for Phase III of this study is to expand the research group to 20 EPM equine that comply with the guidelines set forth in EPM Protocol Objective.
Phase III Conclusion:
The group of 20 EPM equine was selected, and the Sefacon was administered. All the test subjects responded to the Sefacon, no complications were noted and as of this report, no re-infection has been reported.
EPM Analysis Phase I EPM Analysis Phase II EPM Analysis Phase III
EPM Analysis Phase IV Conclusion Report Owner Testimonials!
For information on obtaining Sefacon™
contact
Endocrine Technologies, Inc or Indiana
Horse Rescue
|
|
